Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Alpha Tau Medical Ltd. (DRTS) Financial Statements

Free cash flow over the same period: -$16.1M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DRTSAlpha Tau Medical Ltd.Follow DRTS — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
19 Nov, in 26 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Research & development11.420.926.427.032.1—
Operating income-13.8-32.1-35.7-36.0-42.3-50.4
Pre-tax income-27.3-33.7-29.1-31.7-42.5-92.4
Income tax0.00.00.00.00.10.2
Net income-27.3-33.8-29.2-31.8-42.6-92.6
Diluted EPS ($)-0.67-0.53-0.42-0.45-0.53-1.04
Diluted shares (mn)40.563.569.469.980.6—

USD millions · SEC XBRL

Alpha Tau Medical Ltd. — questions

What is Alpha Tau Medical Ltd.'s net income?
-$92.6M over the twelve months to 2026-06-30.
What is Alpha Tau Medical Ltd.'s free cash flow?
-$16.1M over the twelve months to 2026-06-30.
What are Alpha Tau Medical Ltd.'s diluted earnings per share?
$-1.04 over the twelve months to 2026-06-30.

Every figure on this page comes from Alpha Tau Medical Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.